|By PR Newswire||
|April 14, 2014 02:02 AM EDT||
CHERTSEY, England, April 14, 2014 /PRNewswire/ --
$150,000 Grant awarded to study led by Dr Marianne Gamper
The Astellas European Foundation is pleased to announce the recipient of the 2014 Functional Urology and Uro-Gynaecology Grant as Dr Marianne Gamper for a project to be undertaken jointly in Austria and Switzerland to quantify marker levels to identify the potential relationship between Overactive Bladder Syndrome (OAB) and Bladder Pain Syndrome / Interstitial Cystitis. The successful project team represents three different centres: Kantonsspital Frauenfeld and ETH Zürich (Switzerland) and Medizinische Universität Graz (Austria).
At an event announcing the winner in Stockholm, Sweden, last night the Astellas European Foundation emphasised their continued and long term commitment to research and development. Dr Ayad Abdulahad, Astellas European Foundation Trustee and Head of Medical Affairs and Health Economics for Astellas Pharma Europe Ltd. commented, "We received 35 entries from across Europe. The Foundation would like to thank all of those who submitted research proposals. The standard of entries was very high, and covered a broad range of topics in functional urology and also those in uro-gynaecology. The project led by Dr Gamper and the research team has the potential to verify a hypothesis that could lead to improved early diagnosis and more targeted treatment for OAB and bladder pain syndrome / interstitial cystitis patients."
Dr Marianne Gamper, Kantonsspital Frauenfeld, said "We want to identify, quantify, and compare molecular marker levels in patient samples and associate the results with the severity of clinical findings. The prize money directly provides the essential financial support for our laboratory work, thereby enabling us to continue our fundamental and important research on debilitating chronic bladder diseases."
The Astellas European Foundation is a registered charity with the long-term goal of providing support for programmes and activities that advance our understanding of medicine and health. The Astellas European Foundation Urology Grant supports basic medical and related scientific programmes which contribute to advancements in urology. The winner of the Grant was chosen by a Judging Faculty that includes independent European thought leaders.
The Foundation now offers annual Grants of $150,000 for Functional Urology and Uro-Gynaecology, Uro-Oncology and Transplantation. For information regarding the Grant process please contact the Astellas European Foundation by email at [email protected] or call +44-203-379-8039.
Notes to Editors
About The Astellas European Foundation
The Astellas European Foundation is a registered charity, formed in 2005, with the long-term goal of providing support for programmes and activities that contribute to the advancement of an increasingly healthy society. In line with this aim, the Foundation has made substantial donations to global charities. The Astellas European Foundation also supports Astellas employees in their private fundraising efforts for charitable causes. The Astellas European Foundation is registered with the Charity Commission for England and Wales, number 1036344.
The Astellas European Foundation was established by funding from Astellas Pharma Inc, but operates independently of it.
In the 21st century, security on the Internet has become one of the most important issues. We hear more and more about cyber-attacks on the websites of large corporations, banks and even small businesses. When online we’re concerned not only for our own safety but also our privacy. We have to know that hackers usually start their preparation by investigating the private information of admins – the habits, interests, visited websites and so on. On the other hand, our own security is in danger bec...
Oct. 26, 2016 09:17 AM EDT
Oct. 26, 2016 09:15 AM EDT Reads: 2,044
Oct. 26, 2016 09:15 AM EDT Reads: 16,577
Oct. 26, 2016 07:30 AM EDT Reads: 11,516
Oct. 26, 2016 07:30 AM EDT Reads: 2,803
Oct. 26, 2016 06:45 AM EDT Reads: 3,395
Oct. 26, 2016 06:15 AM EDT Reads: 2,083
Oct. 26, 2016 06:00 AM EDT Reads: 1,886
Oct. 26, 2016 06:00 AM EDT Reads: 2,046
Oct. 26, 2016 06:00 AM EDT Reads: 1,552
Oct. 26, 2016 06:00 AM EDT Reads: 1,422
Oct. 26, 2016 05:45 AM EDT Reads: 2,560
You have great SaaS business app ideas. You want to turn your idea quickly into a functional and engaging proof of concept. You need to be able to modify it to meet customers' needs, and you need to deliver a complete and secure SaaS application. How could you achieve all the above and yet avoid unforeseen IT requirements that add unnecessary cost and complexity? You also want your app to be responsive in any device at any time. In his session at 19th Cloud Expo, Mark Allen, General Manager of...
Oct. 26, 2016 05:30 AM EDT Reads: 1,025
Oct. 26, 2016 05:30 AM EDT Reads: 1,047
Without lifecycle traceability and visibility across the tool chain, stakeholders from Planning-to-Ops have limited insight and answers to who, what, when, why and how across the DevOps lifecycle. This impacts the ability to deliver high quality software at the needed velocity to drive positive business outcomes. In his general session at @DevOpsSummit at 19th Cloud Expo, Eric Robertson, General Manager at CollabNet, will discuss how customers are able to achieve a level of transparency that e...
Oct. 26, 2016 05:00 AM EDT Reads: 1,000